Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Otonomy initiates additional phase III trial of Otividex for Meniere's disease

July 27, 2018

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

July 25, 2018

Addition of sodium thiosulfate to cisplatin lowers incidence of cisplatin-induced hearing loss

July 24, 2018

Hearing light, no synesthesia required

July 18, 2018

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

EMA gives positive scientific advice on development plan and regulatory pathway for AM-111

May 8, 2018

WHO grants INN seliforant to Sensorion's SENS-111

May 3, 2018

Oricula Therapeutics cleared to begin clinical testing of ORC-13661 in U.S.

Feb. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...